REVTORPYK
Active substance: gedatolisib
INJECTION, POWDER, FOR SOLUTION · GEDATOLISIB 180 mg/1
United StatesActive
Marketing holder: Celcuity Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- GEDATOLISIB · 180 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-e17c-7889-a5be-d4e357e5205f;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 84577-751
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 84577-751 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 84577-751 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 84577-751 · Verified 2026-10-09 · open in source